| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Sustiva | |
| 3 | Generic Name | efavirenz | |
| 4 | Indication | HIV | |
| 5 | IP | Expiring 2013. | |
| 6 | Chemistry | ||
| 7 | Economics | ||
| 8 | Competition | ||
| 9 | Approved | 9/17/98 first approval. | |
| 10 | Developer | ||
| 11 | Clinical Trials |
| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Sustiva | |
| 3 | Generic Name | efavirenz | |
| 4 | Indication | HIV | |
| 5 | IP | Expiring 2013. | |
| 6 | Chemistry | ||
| 7 | Economics | ||
| 8 | Competition | ||
| 9 | Approved | 9/17/98 first approval. | |
| 10 | Developer | ||
| 11 | Clinical Trials |
Martin Shkreli